Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry (SECURE)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
UCB Pharma
ClinicalTrials.gov Identifier:
NCT00844285
First received: February 13, 2009
Last updated: November 16, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: January 2027
  Estimated Primary Completion Date: January 2027 (Final data collection date for primary outcome measure)